UBS AM’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41M Sell
179,440
-42,608
-19% -$7.72M 0.01% 709
2026
Q1
$29.6M Sell
222,048
-3,202
-1% -$510K 0.01% 756
2025
Q4
$39.1M Sell
225,250
-218,004
-49% -$35.8M 0.01% 668
2025
Q3
$84.8M Sell
443,254
-121,207
-21% -$22.3M 0.02% 510
2025
Q2
$168M Buy
564,461
+98,789
+21% +$31M 0.03% 423
2025
Q1
$153M Buy
465,672
+7,021
+2% +$2.12M 0.04% 430
2024
Q4
$133M Buy
458,651
+11,960
+3% +$3.69M 0.03% 457
2024
Q3
$154M Sell
446,691
-33,781
-7% -$11.1M 0.04% 407
2024
Q2
$143M Buy
480,472
+114,255
+31% +$38.8M 0.04% 372
2024
Q1
$150M Buy
366,217
+2,171
+0.6% +$841K 0.05% 339
2023
Q4
$132M Buy
364,046
+10,456
+3% +$3.69M 0.05% 361
2023
Q3
$116M Buy
353,590
+92,626
+35% +$29.2M 0.05% 369
2023
Q2
$69.8M Hold
260,964
0.03% 476
2023
Q1
$69.8M Sell
260,964
-8,628
-3% -$2.48M 0.03% 476
2022
Q4
$89M Buy
269,592
+10,097
+4% +$3.43M 0.05% 414
2022
Q3
$85.6M Sell
259,495
-3,305
-1% -$1.06M 0.05% 410
2022
Q2
$73.5M Buy
262,800
+11,673
+5% +$3.53M 0.04% 458
2022
Q1
$83.8M Sell
251,127
-7,472
-3% -$2.3M 0.04% 485
2021
Q4
$82.3M Sell
258,599
-5,833
-2% -$1.73M 0.03% 520
2021
Q3
$71.7M Sell
264,432
-23,383
-8% -$6.18M 0.03% 540
2021
Q2
$72.8M Sell
287,815
-8,102
-3% -$2.04M 0.03% 525
2021
Q1
$69.2M Sell
295,917
-886
-0.3% -$198K 0.03% 529
2020
Q4
$63.1M Buy
296,803
+5,708
+2% +$1.18M 0.03% 530
2020
Q3
$53.3M Buy
291,095
+17,690
+6% +$3.22M 0.03% 505
2020
Q2
$48.7M Buy
273,405
+192,326
+237% +$32.8M 0.03% 490
2020
Q1
$11.3M Buy
81,079
+7,048
+10% +$943K 0.01% 823
2019
Q4
$10M Sell
74,031
-55,083
-43% -$6.94M 0.01% 946
2019
Q3
$14.2M Buy
129,114
+54,857
+74% +$7.11M 0.01% 851
2019
Q2
$10.6M Buy
74,257
+2,364
+3% +$324K 0.01% 938
2019
Q1
$10.2M Buy
71,893
+7,799
+12% +$1.05M 0.01% 928
2018
Q4
$7.45M Sell
64,094
-14,466
-18% -$1.9M 0.01% 951
2018
Q3
$11.7M Buy
78,560
+19,347
+33% +$2.47M 0.01% 895
2018
Q2
$5.8M Buy
59,213
+19,425
+49% +$1.69M ﹤0.01% 1098
2018
Q1
$3.23M Buy
39,788
+5,142
+15% +$414K ﹤0.01% 1285
2017
Q4
$2.66M Buy
34,646
+1,597
+5% +$115K ﹤0.01% 1318
2017
Q3
$2.27M Buy
33,049
+2,577
+8% +$168K ﹤0.01% 1348
2017
Q2
$2.11M Buy
30,472
+2,165
+8% +$133K ﹤0.01% 1345
2017
Q1
$1.29M Sell
28,307
-34,450
-55% -$1.8M ﹤0.01% 1535
2016
Q4
$3.41M Buy
62,757
+30,033
+92% +$1.64M ﹤0.01% 1090
2016
Q3
$1.91M Sell
32,724
-26,887
-45% -$1.48M ﹤0.01% 1397
2016
Q2
$2.98M Buy
59,611
+15,630
+36% +$835K ﹤0.01% 1205
2016
Q1
$2.84M Sell
43,981
-56,920
-56% -$3.38M ﹤0.01% 1224
2015
Q4
$6.07M Buy
100,901
+30,660
+44% +$1.93M 0.01% 1004
2015
Q3
$4.84M Buy
70,241
+46,726
+199% +$3.47M 0.01% 1058
2015
Q2
$1.65M Buy
23,515
+7,516
+47% +$503K ﹤0.01% 1486
2015
Q1
$1.08M Buy
15,999
+3,700
+30% +$214K ﹤0.01% 1601
2014
Q4
$658K Buy
12,299
+800
+7% +$38.7K ﹤0.01% 1789
2014
Q3
$486K Buy
11,499
+800
+7% +$35.4K ﹤0.01% 1900
2014
Q2
$477K Buy
10,699
+300
+3% +$12.2K ﹤0.01% 1926
2014
Q1
$391K Buy
10,399
+100
+1% +$3.69K ﹤0.01% 2026
2013
Q4
$358K Buy
10,299
+400
+4% +$13.5K ﹤0.01% 2010
2013
Q3
$352K Hold
9,899
﹤0.01% 1979
2013
Q2
$368K Buy
+9,899
New +$350K ﹤0.01% 1865

Other funds holding MOH

UBS AM's MOH Position: Q2 2026 in Review

UBS AM reduced its Molina Healthcare (MOH) stake by 19% in Q2 2026, selling an estimated $7.72M and leaving 179,440 shares worth $41M. The position accounts for 0.01% of the portfolio, ranked #709.

UBS AM first reported a position in MOH in Q2 2013 and has held it in 53 quarters since. The position peaked at $168M in Q2 2025. 598 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • UBS AM held 179,440 shares of Molina Healthcare worth $41M as of Q2 2026.
  • UBS AM sold 42,608 Molina Healthcare shares in Q2 2026, an estimated $7.72M.
  • Molina Healthcare made up 0.01% of UBS AM's portfolio in Q2 2026, its #709 holding.
  • UBS AM first reported a position in Molina Healthcare in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Molina Healthcare position peaked at $168M in Q2 2025.
  • 598 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.